{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:59:08Z","timestamp":1761393548515},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,14]],"date-time":"2006-07-14T00:00:00Z","timestamp":1152835200000},"content-version":"vor","delay-in-days":4181,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Chromosomes & Cancer"],"published-print":{"date-parts":[[1995,2]]},"abstract":"Abstract<\/jats:title>Breast cancer can relapse both locally and at distant metastatic sites. The mechanism of Iocal recurrence is unknown, but seems to be due not only to the number of residual cancer cells (inadequate irradiation or surgery), but also to their genetically determined malignant potential. To identify genetic alterations associated with local recurrence risk in breast carcinoma, we analyzed 28 local recurrences and 173 primary breast tumors for the ten most frequently altered genetic regions in breast carcinomas, i.e., loss of heterozygosity on chromosomal arms 1p, 3p, 7q, 11p, 17p, 17q, and 18q, and amplification of the MYC<\/jats:italic> and ERBB2<\/jats:italic> protooncogenes and of genes in 11q13. Only INT2\/FGF3<\/jats:italic> and CCND1<\/jats:italic>, located in 11q13, were more frequently amplified in local recurrences than in primary tumors (39% vs. 17%; P<\/jats:italic> < 0.01). Moreover, recurrence\u2010free survival was shorter when the 11q13 region was amplified. These results suggest that one or more genes located in 11q13 play an important role in local relapses of breast cancer.<\/jats:p>","DOI":"10.1002\/gcc.2870120207","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T00:14:03Z","timestamp":1172103243000},"page":"128-133","source":"Crossref","is-referenced-by-count":31,"title":["11q13 Amplification in local recurrence of human primary breast cancer"],"prefix":"10.1002","volume":"12","author":[{"given":"Marie\u2010H\u00e9l\u00e8ne","family":"Champ\u00e8me","sequence":"first","affiliation":[]},{"given":"Ivan","family":"Bi\u00e8che","sequence":"additional","affiliation":[]},{"given":"Sarab","family":"Lizard","sequence":"additional","affiliation":[]},{"given":"Rosette","family":"Lidereau","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2006,7,14]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1389","article-title":"Proto\u2010oncogene amplification and breast tumour phenotype","volume":"4","author":"Adnane J","year":"1989","journal-title":"Oncogene"},{"key":"e_1_2_1_3_1","first-page":"139","article-title":"Lack of evidence for the prognostic significance of c\u2010erbB\u20102 amplification in human breast carcinoma","volume":"3","author":"Ali IU","year":"1988","journal-title":"Oncogene Res"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.23.1815"},{"key":"e_1_2_1_5_1","first-page":"89","article-title":"The amplification unit on chromosome 11q13 in aggresive primary human breast tumors contains the bcl\u20101, int\u20102 and hst loci","volume":"4","author":"Ali IU","year":"1989","journal-title":"Oncogene"},{"key":"e_1_2_1_6_1","first-page":"1107","article-title":"C\u2010myc amplification is a better pronostic factor than HER2\/neu amplification in primary breast cancer","volume":"52","author":"Berns EMJJ","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00276332"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90208-K"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870060406"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.19.7737"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.1.45"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.13.4834"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90186-I"},{"key":"e_1_2_1_14_1","first-page":"6675","article-title":"Genetic alterations of c\u2010myc, c\u2010erbB\u20102, and c\u2010Ha\u2010ras protooncogenes and clinical associations in human breast carcinomas","volume":"49","author":"Garcia I","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910530512"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000133157"},{"key":"e_1_2_1_17_1","first-page":"439","article-title":"D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL1","volume":"6","author":"Lammie GA","year":"1991","journal-title":"Oncogene"},{"key":"e_1_2_1_18_1","first-page":"285","article-title":"Amplification of the int\u20102 gene in primary human breast tumors","volume":"2","author":"Lidereau R","year":"1988","journal-title":"Oncogene Res"},{"key":"e_1_2_1_19_1","volume-title":"Molecular Cloning: A Laboratory Manual","author":"Maniatis T","year":"1982"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/350512a0"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/342705a0"},{"key":"e_1_2_1_22_1","first-page":"449","article-title":"Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors","volume":"6","author":"Rosenberg CL","year":"1991","journal-title":"Oncogene"},{"key":"e_1_2_1_23_1","first-page":"403","article-title":"GSTS gene is frequently coamplified with INT2 and HSTF1 proto\u2010oncogenes in human breast cancers","volume":"6","author":"Saint\u2010Ruf C","year":"1990","journal-title":"Oncogene"},{"key":"e_1_2_1_24_1","first-page":"5229","article-title":"Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer","volume":"52","author":"Schuuring E","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_25_1","first-page":"355","article-title":"Identification and cloning of two overexpressed genes, U21B31\/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas","volume":"7","author":"Schuuring E","year":"1992","journal-title":"Oncogene"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000133722"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"e_1_2_1_28_1","first-page":"369","volume-title":"Breast Diseases","author":"Smith IE","year":"1987"},{"key":"e_1_2_1_29_1","first-page":"4776","article-title":"Loss of a c\u2010Ha\u2010ras\u20101 allele and aggressive human primary breast carcinomas","volume":"46","author":"Theillet C","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/369669a0"}],"container-title":["Genes, Chromosomes and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgcc.2870120207","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/gcc.2870120207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T20:31:21Z","timestamp":1698265881000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gcc.2870120207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1002\/gcc.2870120207"],"URL":"https:\/\/doi.org\/10.1002\/gcc.2870120207","archive":["Portico"],"relation":{},"ISSN":["1045-2257","1098-2264"],"issn-type":[{"value":"1045-2257","type":"print"},{"value":"1098-2264","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}